Peer-reviewedCC BYCancer communications
Metabolic Competition-Driven Antitumor Immunity of glpX-Deficient Engineered Salmonella via Glucose Deprivation and STING Activation in Bladder Cancer
- 1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences , Nanjing University , Nanjing, Jiangsu, .
- 2Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy , Dali University , Dali, Yunnan, .
- 3College of Life Sciences and Medicine , Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine , Zhejiang Sci-Tech University , Hangzhou, Zhejiang, .
Related
- Metabolic engineering of Salmonella enterica for coupled kynurenine sensing and depletion enhances antitumor efficacy
- Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint
- Targeting SLC6A14-mediated nutrient competition reverses an immunosuppressive metabolic niche in pancreatic cancer.
- Modulation of riboflavin biosynthesis enzymes in non-typhoidal Salmonella isolates differentially impacts human MAIT cell activation
- Metabolic signals and innate immune activation in obesity and exercise
BibTeX
@article{wu2026metabolic,
title = {{Metabolic Competition-Driven Antitumor Immunity of glpX-Deficient Engineered Salmonella via Glucose Deprivation and STING Activation in Bladder Cancer}},
author = {Leyang Wu and Xinyue Qiao and Wanru Wang and Jiahui Qiu and Xiao Dong and Liyuan Qiao and Chengxuan Lei and Xiaoxin Zhang and Ying Sun and Chenyang Li and Bohao Wang and Zengzheng Du and Heng Liu and Zhengbing Lv and Xiaofeng Jiang and Zichun Hua},
journal = {Cancer communications},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13669507},
note = {CC BY},
}
RIS
TY - JOUR
TI - Metabolic Competition-Driven Antitumor Immunity of glpX-Deficient Engineered Salmonella via Glucose Deprivation and STING Activation in Bladder Cancer
AU - Leyang Wu
AU - Xinyue Qiao
AU - Wanru Wang
AU - Jiahui Qiu
AU - Xiao Dong
AU - Liyuan Qiao
AU - Chengxuan Lei
AU - Xiaoxin Zhang
AU - Ying Sun
AU - Chenyang Li
AU - Bohao Wang
AU - Zengzheng Du
AU - Heng Liu
AU - Zhengbing Lv
AU - Xiaofeng Jiang
AU - Zichun Hua
PY - 2026
DA - 2026/10/19
JO - Cancer communications
UR - https://europepmc.org/article/PMC/PMC13669507
SN - 0955-3541
SN - 2523-3548
ER -